跳至主要内容
临床试验/NCT03201510
NCT03201510已完成不适用

HPTN 075: Feasibility of HIV Prevention Cohort Studies Among Men Who Have Sex With Men in Sub-Saharan Africa

HIV Prevention Trials Network4 个研究点 分布在 3 个国家目标入组 401 人开始时间: 2015年6月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
401
试验地点
4
主要终点
Retention of approximately 400 participants

研究概览

简要总结

This study aims to determine the feasibility of recruiting and retaining men who have sex with men (MSM) in a multi-country prospective cohort study in preparation for human immunodeficiency virus (HIV) prevention studies in sub-Saharan Africa (SSA).

详细描述

HPTN 075 is an observational cohort study. Participants will be accrued over six months at four sites in SSA using convenience sampling strategies, with no replacement for participants lost to follow-up. Each participant will be followed for 12 months, during which five study visits involving structured HIV behavioral assessments, medical examinations, and collection of biological samples will be conducted (including enrollment and quarterly follow-up visits). Participants who do not complete 12 months of follow-up will be contacted to explore reasons for no longer participating.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 44 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Biologically male at birth, according to self-report;
  • 18-44 years old (inclusive);
  • Willing and able to provide informed consent;
  • Willing to undergo HIV testing throughout the study and to receive those test results;
  • Reporting at least one act of anal intercourse in the previous 3 months (12 weeks) with a person reported by the participant to be biologically male;
  • Able to provide complete locator identification for themselves and at least two other personal contacts;
  • Willing to participate in all scheduled study assessments, including specimen collection, laboratory assessments, and sample storage;
  • Committing to not participate in any HIV intervention or vaccine study while participating in HPTN 075;
  • Planning to remain in the study area for at least one year;
  • For HIV-uninfected men: All HIV test results at the Screening visit must be non-reactive/negative;
  • For HIV-infected men (up to 20 per site): All HIV test results at the Screening visit must be reactive/positive.
  • Men who are already on PrEP will not be excluded. Additionally, self- or other-identified transgender women and male sex workers will not be excluded. There will, however, be no specific effort to recruit these groups.

排除标准

  • Unwilling to adhere to study procedures;
  • Past or current participation in a biomedical and/or behavioral HIV/STI intervention or cohort study, including HIV vaccine studies; however, participation in local/area PrEP demonstration projects does not preclude participation in HPTN 075;
  • HIV-infected men who report that they are already on ART or in HIV care;
  • Any other reason or condition that in the opinion of the Investigator of Record (IOR) would interfere with participation, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
  • Men who have discordant HIV test results at Screening (i.e., at least one reactive or positive result and at least one non-reactive or negative result). These men will receive HIV counseling and will be referred for further diagnostic tests and care.

结局指标

主要结局

Retention of approximately 400 participants

时间窗: July 2015-July 2016

at least 90% of participants must be retained

Recruitment of approximately 400 participants

时间窗: July 2015-July 2016

all 4 sites must collectively recruit 400 participants

次要结局

  • HIV incidence(July 2015-July 2017)

研究者

发起方
HIV Prevention Trials Network
申办方类型
Network
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验